Key facts
- This page summarizes Joseph P. Hagan's Form 4 filing for Aurinia Pharmaceuticals Inc. (AUPH).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 23 May 2023, 17:18.
Joseph P. Hagan - 18 May 2023 Form 4 Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)
- Reporting relationship
- Director
- Issuer ticker
- AUPH
- Reported as of
- 18 May 2023
- Net transaction value
- -$2,878
- SEC form
- 4
- Accepted by SEC
- 23 May 2023, 17:18:43 UTC
- Prior SEC filing
- 17 Jan 2023
- Next SEC filing
- 14 Aug 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Joseph P. Hagan
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Joseph P. Hagan filed Form 4 for Aurinia Pharmaceuticals Inc. (AUPH) on 23 May 2023.
Change
- Previous filing in this sequence was filed on 17 Jan 2023.
- Current net transaction value: -$2,878.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AUPH
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +8,733
- Change %
- +250%
- Price
- Shares after
- 12,233
- Date
- 18 May 2023
- Ownership
- Direct
- Footnotes
- F1
AUPH
transaction
Common Stock
Sale
- Transaction value
- $2,878
- Shares
- -272
- Change %
- -2.2%
- Price
- $10.58
- Shares after
- 11,961
- Date
- 19 May 2023
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AUPH
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -8,733
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 18 May 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 8,733
- Exercise price
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of Issuer Common Stock. The RSUs have no expiration date.
Footnote F2
Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of RSUs.